Key facts
- Pow.bio’s last known valuation is $33.3M (Apr 2025).
- It has raised $19.3M; the latest was Later Stage VC ($5.4M) in Apr 2025.
- Notable investors include Plug and Play Tech Center, US National Science Foundation, Climate Capital, Gaingels, U.S. Department of Energy — 25 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for Pow.bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Pow.bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pow.bio
Developer of a fermentation technology designed to transform biomanufacturing by replacing traditional fed-batch methods with AI-driven processes. The company's technology offers bioreactor-agnostic hardware, real-time AI process control, and stable long-run fermentation capabilities, enabling biotech, food, and industrial producers to lower production costs, accelerate time-to-market, and scale sustainable bio-based products.
- Sector
- Healthcare
- HQ
- Berkeley, CA, United States
- Founded
- 2019
- Employees
- 27
- Website
- pow.bio/
- Ownership
- Privately Held (backing)
Pow.bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pow.bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pow.bio in its N-PORT filings yet. We sweep new filings monthly.